FDA Releases Questions and Answers about ESA Medication Guides

The Food and Drug Administration now provides answers to questions about using erythropoiesis-stimulating agents (ESAs) and their FDA-approved Medication Guides.  The Medication Guides are now part of labeling for ESAs Aranesp® (darbepoetin alfa), Epogen® (epoetin alfa), and Procrit® (epoetin alfa). The Guides are designed to help patients make informed decisions about the risks and benefits of…  Read More